Stocks and Investing Stocks and Investing
Thu, November 2, 2023
[ 12:00 AM ] - United States, WOPRAI
Andrew Mok Maintained (THC) at Strong Buy with Decreased Target to $94 on, Nov 2nd, 2023
[ 12:00 AM ] - United States, WOPRAI
Kenneth Zener Upgraded (TMHC) to Strong Buy and Held Target at $50 on, Nov 2nd, 2023
[ 12:00 AM ] - United States, WOPRAI
Manav Patnaik Maintained (TRI) at Hold with Decreased Target to $130 on, Nov 2nd, 2023
[ 12:00 AM ] - United States, WOPRAI
Drew McReynolds Maintained (TRI) at Hold with Decreased Target to $133 on, Nov 2nd, 2023
[ 12:00 AM ] - United States, WOPRAI
Toni Kaplan Maintained (TRI) at Hold with Decreased Target to $130 on, Nov 2nd, 2023
[ 12:00 AM ] - United States, WOPRAI
Jerry Revich Maintained (TRMB) at Strong Buy with Decreased Target to $58 on, Nov 2nd, 2023
[ 12:00 AM ] - United States, WOPRAI
Tami Zakaria Maintained (TRMB) at Hold with Decreased Target to $48 on, Nov 2nd, 2023
[ 12:00 AM ] - United States, WOPRAI
Richard Shane Maintained (TRTX) at Hold with Decreased Target to $6 on, Nov 2nd, 2023
[ 12:00 AM ] - United States, WOPRAI
Justin Jenkins Maintained (SUN) at Buy with Increased Target to $55 on, Nov 2nd, 2023
[ 12:00 AM ] - United States, WOPRAI
Alexander Paris Maintained (STRA) at Buy with Increased Target to $100 on, Nov 2nd, 2023
[ 12:00 AM ] - United States, WOPRAI
Connor Lynagh Maintained (STT) at Hold with Decreased Target to $77 on, Nov 2nd, 2023
[ 12:00 AM ] - United States, WOPRAI
Mike Cikos Maintained (TENB) at Strong Buy with Decreased Target to $45 on, Nov 2nd, 2023
[ 12:00 AM ] - United States, WOPRAI
Daniel Ives Maintained (TENB) at Buy with Decreased Target to $50 on, Nov 2nd, 2023
[ 12:00 AM ] - United States, WOPRAI
Brian Colley Maintained (TENB) at Buy with Decreased Target to $55 on, Nov 2nd, 2023
[ 12:00 AM ] - United States, WOPRAI
Saket Kalia Maintained (TENB) at Hold with Decreased Target to $41 on, Nov 2nd, 2023
[ 12:00 AM ] - United States, WOPRAI
Hamza Fodderwala Maintained (TENB) at Hold with Decreased Target to $46 on, Nov 2nd, 2023
[ 12:00 AM ] - United States, WOPRAI
Rob Owens Maintained (TENB) at Buy with Decreased Target to $50 on, Nov 2nd, 2023
[ 12:00 AM ] - United States, WOPRAI
Ronald Epstein Maintained (TDY) at Strong Buy with Decreased Target to $430 on, Nov 2nd, 2023
[ 12:00 AM ] - United States, WOPRAI
Daniel Arias Maintained (TECH) at Strong Buy with Decreased Target to $65 on, Nov 2nd, 2023
[ 12:00 AM ] - United States, WOPRAI
Mark Moskowitz Maintained (CDW) at Hold with Increased Target to $219 on, Nov 2nd, 2023
[ 12:00 AM ] - United States, WOPRAI
Erik Woodring Maintained (CDW) at Buy with Decreased Target to $216 on, Nov 2nd, 2023
[ 12:00 AM ] - United States, WOPRAI
William Crow Maintained (cdp) at Buy with Decreased Target to $27 on, Nov 2nd, 2023
[ 12:00 AM ] - United States, WOPRAI
Andrew Fein Maintained (CCCC) at Strong Buy with Decreased Target to $7 on, Nov 2nd, 2023
[ 12:00 AM ] - United States, WOPRAI
Ric Prentiss Maintained (DBRG) at Strong Buy with Decreased Target to $24 on, Nov 2nd, 2023
[ 12:00 AM ] - United States, WOPRAI
Ken Herbert Maintained (SPR) at Hold with Increased Target to $25 on, Nov 2nd, 2023
[ 12:00 AM ] - United States, WOPRAI
Seth Seifman Maintained (SPR) at Buy with Increased Target to $38 on, Nov 2nd, 2023
[ 12:00 AM ] - United States, WOPRAI
David Karnovsky Maintained (SRAD) at Buy with Decreased Target to $12 on, Nov 2nd, 2023
[ 12:00 AM ] - United States, WOPRAI
Gil Blum Maintained (SRPT) at Strong Buy with Increased Target to $93 on, Nov 2nd, 2023
[ 12:00 AM ] - United States, WOPRAI
Kristen Kluska Maintained (SRPT) at Hold with Increased Target to $80 on, Nov 2nd, 2023
[ 12:00 AM ] - United States, WOPRAI
Gena Wang Maintained (SRPT) at Buy with Decreased Target to $141 on, Nov 2nd, 2023

Gena Wang Maintained (SRPT) at Buy with Decreased Target to $141 on, Nov 2nd, 2023


Published on 2024-10-28 07:17:40 - WOPRAI, Gena Wang
  Print publication without navigation


Gena Wang of Barclays, Maintained "Sarepta Therapeutics, Inc." (SRPT) at Buy with Decreased Target from $193 to $141 on, Nov 2nd, 2023.

Gena has made no other calls on SRPT in the last 4 months.



There are 4 other peers that have a rating on SRPT. Out of the 4 peers that are also analyzing SRPT, 0 agree with Gena's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Gena

  • Anupam Rama of "JP Morgan" Maintained at Buy with Decreased Target to $115 on, Tuesday, October 31st, 2023
  • Brian Abrahams of "RBC Capital" Maintained at Buy with Decreased Target to $148 on, Tuesday, October 31st, 2023
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $146 on, Tuesday, October 31st, 2023
  • Uy Ear of "Mizuho" Reiterated at Strong Buy and Held Target at $160 on, Tuesday, September 26th, 2023

Contributing Sources